Sovereign Nations. Different Laws. One Complicated Payments System.
Sovereign Nations. Different Laws. One Complicated Payments System. On Indigenous Peoples' Day, it's time to examine why tribal gaming, ...
New Hampshire Attorney General John Formella has joined 37 other state attorneys general in urging Congress to close a federal loophole that allows the sale of synthetic and intoxicating hemp-derived products linked to emergency room visits, particularly among children. The coordinated multi-state effort highlights growing concern about chemically altered THC products sold in gas stations and convenience stores under appealing brand names and packaging that resembles candy.
The attorneys general are calling on Congress to clarify the legal definition of "hemp" to explicitly exclude synthetic and intoxicating THC products that have been chemically altered from hemp-derived compounds. According to reporting from WMUR, these products are currently sold legally across New Hampshire and many other states despite concerns about their safety profile and appeal to minors.
The products in question include Delta-8 THC, HHC (hexahydrocannabinol), and THCO (THC-O-acetate)—compounds that are either naturally present in hemp in trace amounts or created through chemical processes that convert CBD or other hemp cannabinoids into intoxicating substances. Some consumers refer to these products as "Frankenstein weed" on social media, acknowledging their synthetic or semi-synthetic nature.
Assistant Attorney General Warren Cormack stated that the effects of these products can exceed those of traditional marijuana, with greater incidences of hospitalizations following consumption. The products are sold under brand names like Moonwalker and Exhale Wellness, often in packaging featuring bright colors and designs that appeal to younger consumers.
The multi-state attorney general letter emphasizes a troubling pattern: products designed to look like candy or popular beverages, sold in locations accessible to minors, containing intoxicating compounds that can produce strong psychoactive effects and send consumers to emergency rooms. Officials with the New Hampshire Attorney General's Office have specifically noted that parents often don't realize the gummy or soda their child sees on a store shelf could result in hospitalization.
Calls related to hemp-derived Delta-8 THC products have increased substantially since these products entered widespread commercial distribution. The concern extends beyond accidental pediatric exposure to include products that may contain inconsistent or inaccurately labeled cannabinoid content, creating unpredictable effects even for adult consumers.
The 2018 Farm Bill legalized hemp containing less than 0.3% Delta-9 THC by dry weight, intending to support industrial hemp production and non-intoxicating CBD products. However, manufacturers discovered they could chemically convert legal hemp-derived CBD into Delta-8 THC and other intoxicating compounds that technically fall outside the legal definition of controlled substances, creating the loophole attorneys general now want closed.
While the attorney general push targets synthetic and potentially dangerous products, the regulatory uncertainty affects all businesses in the hemp and CBD space. Companies producing legitimate, tested hemp products face market competition from manufacturers selling unregulated intoxicating products at lower price points without investing in proper quality control, testing, or compliance infrastructure.
For businesses committed to operating responsibly, the current environment creates multiple challenges. Merchant processors and financial institutions often cannot distinguish between compliant hemp businesses and companies selling synthetic intoxicating products, leading to blanket restrictions or account terminations that affect the entire industry. Consumers may confuse high-quality, tested CBD products with questionable synthetic alternatives, damaging trust in the broader hemp market.
Businesses using comprehensive quality management systems like Q-Trust can differentiate themselves by demonstrating rigorous testing protocols, accurate labeling, and transparent supply chain documentation. As regulatory scrutiny increases, companies with robust compliance documentation will be better positioned to maintain market access, merchant processing relationships, and consumer confidence.
While attorneys general call for federal action, states have taken varied approaches to regulating hemp-derived intoxicating products. Some states have implemented age restrictions, licensing requirements, or outright bans on Delta-8 and similar compounds. Others have left the products largely unregulated pending federal clarification.
This creates significant compliance challenges for businesses operating across state lines. A product formulation that's legal in one jurisdiction may be prohibited in another. Marketing language acceptable in some states may violate restrictions elsewhere. Without systematic compliance tracking across all operational jurisdictions, businesses risk inadvertent violations that trigger enforcement actions or merchant account suspensions.
Certificate of Analysis management becomes especially critical in this environment. Businesses must be able to quickly demonstrate the cannabinoid profile of every product, showing that formulations comply with varying state-level THC limits and don't contain prohibited synthetic compounds. COAs must come from accredited laboratories and accurately reflect product contents to withstand regulatory scrutiny.
If Congress acts on the attorneys general request, businesses selling hemp-derived products could face sudden compliance requirements. Federal legislation might impose limits on total THC content regardless of the specific cannabinoid variant, require age verification for all hemp product sales, mandate testing for synthetic cannabinoids, or restrict product packaging and marketing that appeals to minors.
Companies should prepare for potential regulatory changes by implementing several proactive measures: comprehensive COA management that documents the complete cannabinoid profile of all products, age verification systems for online and in-person sales, packaging and marketing audits to identify elements that could be viewed as appealing to minors, and supply chain documentation that traces products from compliant hemp sources through final sale.
Businesses relying on synthetic or semi-synthetic cannabinoid products should particularly evaluate their exposure to regulatory risk. While these products may currently occupy a legal gray area, the coordinated multi-state attorney general push suggests regulatory tightening is likely. Companies heavily invested in Delta-8, HHC, THCO, or similar compounds should consider diversification strategies and compliance infrastructure that can adapt to stricter federal standards.
As regulatory pressure increases on problematic hemp products, businesses operating with rigorous quality standards have an opportunity to differentiate themselves in the marketplace. Companies that invest in proper testing, accurate labeling, child-resistant packaging, and transparent communication about product effects position themselves as responsible industry participants rather than regulatory targets.
Q-Trust's compliance monitoring capabilities help businesses stay ahead of regulatory changes by tracking proposed legislation across multiple jurisdictions, alerting companies to emerging restrictions, and documenting compliance efforts that demonstrate good faith to regulators and business partners. When federal standards eventually clarify, businesses with established quality management infrastructure will adapt more easily than competitors scrambling to implement compliance systems reactively.
The multi-state attorney general push for federal hemp regulation signals that the current permissive environment for synthetic cannabinoid products will not last indefinitely. Hemp businesses that establish robust compliance systems, comprehensive testing protocols, and transparent quality management now will be positioned to thrive when regulations tighten, while competitors without proper infrastructure face market disruption or closure.
Don't wait for federal regulations to force compliance changes. Contact Qredible today to discover how Q-Trust can help your hemp business implement the quality management systems, COA tracking, and compliance monitoring that will differentiate your brand and ensure long-term market viability as regulations evolve.
